Wolfgang Boehmerle

Charite Universitatsmedizin Berlin Klinik für Neurologie mit Experimenteller Neurologie

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Werner Stenzel

Head of Neuromuscular Diagnostic and Research unit/ Professor Dr. med.

Charité - Universitätsmedizin Berlin

GERMANY

View details

Matthias Endres

Prof. Dr. med.

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin

GERMANY

View details

Yangfan Peng

Charité - Universitätsmedizin Berlin

GERMANY

View details

Raphael Mohr

Charité - Universitätsmedizin Berlin

GERMANY

View details

Valeria Fernandez Vallone

Charité - Universitätsmedizin Berlin

GERMANY

View details

Hanna Muenzfeld

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wolfgang Boehmerle

Research Interests

Explore related searches

Contact this professor

Articles (17)

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis

Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events.

Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events.

Smell and Taste Alterations in Patients Receiving Curative or Palliative Chemotherapy—The CONKO 021—ChemTox Trial

Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study.

Unique brain injury patterns after proton vs photon radiotherapy for WHO grade 2-3 gliomas.

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.

Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.

Induced pluripotent stem cell-derived brain organoids as potential human model system for chemotherapy induced CNS toxicity.

Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy.

Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial - Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial.

Dataset for: Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons

Cognitive impairment after cytotoxic chemotherapy

Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice

Bortezomib at therapeutic doses poorly passes the blood–brain barrier and does not impair cognition

Collaborators (6)

Werner Stenzel

Matthias Endres

Yangfan Peng

Raphael Mohr

Valeria Fernandez Vallone

Hanna Muenzfeld

Make your next move.

Wolfgang Boehmerle

Research Interests

Explore related searches

Contact this professor

Articles (17)

HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis

Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events.

Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events.

Smell and Taste Alterations in Patients Receiving Curative or Palliative Chemotherapy—The CONKO 021—ChemTox Trial

Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study.

Unique brain injury patterns after proton vs photon radiotherapy for WHO grade 2-3 gliomas.

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.

Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.

Induced pluripotent stem cell-derived brain organoids as potential human model system for chemotherapy induced CNS toxicity.

Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy.

Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial - Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial.

Dataset for: Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons

Cognitive impairment after cytotoxic chemotherapy

Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice

Bortezomib at therapeutic doses poorly passes the blood–brain barrier and does not impair cognition

Collaborators (6)

Werner Stenzel

Matthias Endres

Yangfan Peng

Raphael Mohr

Valeria Fernandez Vallone

Hanna Muenzfeld

Make your next move.

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis